TheProfitWatch

CRVS - Corvus Pharmaceuticals, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
7.24 0.46 (6.35%) 0.0 (0.0%) 0.01 (0.13%) 0.0 (0.0%) 0.01 (0.14%) 0.57 (7.99%) -0.02 (-0.26%) -0.02 (-0.26%)

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.1
Diluted EPS:
-0.1
Basic P/E:
-77.0
Diluted P/E:
-77.0
RSI(14) 1m:
100.0
VWAP:
7.7
RVol:
2.3483

Events

Period Kind Movement Occurred At
1m Price increase 1m 7.0 +0.07 (+1.01%) Oct 15 14:02
1m Price increase 1m 7.2 +0.09 (+1.34%) Oct 15 09:36
1m Price increase 1m 7.21 +0.08 (+1.12%) Oct 15 09:30

Related News